Anti-cancer activity and mechanistic features of a NK cell activating molecule

Hyung Ran Kim, Kyoung Ho Lee, Su Jung Park, So Young Kim, Young Keun Yang, Jinsung Tae, Jongsun Kim

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Natural cytotoxicity receptors (NCRs) are major activating receptors involved in NK cytotoxicity. NCR expression varies with the activation state of NK cells, and the expression level correlates with NK cells' natural cytotoxicity. In this study, we found that Gö6983, a PKC inhibitor, induced a remarkable increase of NCR expression on primary NK cells, but other PKC inhibitors and NK cell stimulators such as IL-2 and PMA, did not. Gö6983 increased the expression of NCR in a time- and concentration-dependent manner. Furthermore, Gö6983 strongly upregulated the surface expression of death ligands FasL and TRAIL, but not cytotoxic molecules perforin and granzyme B. Unlike two other NK stimulating molecules, IL-2, and PMA, Gö6983 did not induce NK cell proliferation. Up-regulation of NCRs and death ligands on NK cells by Gö6983 resulted in a significant enhancement of NK cytotoxicity against various cancer cell lines. Most importantly, administration of Gö6983 effectively inhibited pulmonary tumor metastasis in mice in a dose-dependent manner. These results suggest that Gö6983 functions as an NK cell activating molecule (NKAM); this NKAM is a novel anti-cancer and anti-metastasis drug candidate because it enhances NK cytotoxicity against cancer cells in vivo as well as in vitro.

Original languageEnglish
Pages (from-to)1691-1700
Number of pages10
JournalCancer Immunology, Immunotherapy
Volume58
Issue number10
DOIs
Publication statusPublished - 2009 Oct 1

Fingerprint

Natural Killer Cells
Neoplasms
Interleukin-2
Neoplasm Metastasis
Ligands
Death Domain Receptors
Population Growth
Up-Regulation
Cell Proliferation
Cell Line
Lung
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Cancer Research

Cite this

Kim, Hyung Ran ; Lee, Kyoung Ho ; Park, Su Jung ; Kim, So Young ; Yang, Young Keun ; Tae, Jinsung ; Kim, Jongsun. / Anti-cancer activity and mechanistic features of a NK cell activating molecule. In: Cancer Immunology, Immunotherapy. 2009 ; Vol. 58, No. 10. pp. 1691-1700.
@article{cd3fa23576e54cf8b42ee6e811577cf5,
title = "Anti-cancer activity and mechanistic features of a NK cell activating molecule",
abstract = "Natural cytotoxicity receptors (NCRs) are major activating receptors involved in NK cytotoxicity. NCR expression varies with the activation state of NK cells, and the expression level correlates with NK cells' natural cytotoxicity. In this study, we found that G{\"o}6983, a PKC inhibitor, induced a remarkable increase of NCR expression on primary NK cells, but other PKC inhibitors and NK cell stimulators such as IL-2 and PMA, did not. G{\"o}6983 increased the expression of NCR in a time- and concentration-dependent manner. Furthermore, G{\"o}6983 strongly upregulated the surface expression of death ligands FasL and TRAIL, but not cytotoxic molecules perforin and granzyme B. Unlike two other NK stimulating molecules, IL-2, and PMA, G{\"o}6983 did not induce NK cell proliferation. Up-regulation of NCRs and death ligands on NK cells by G{\"o}6983 resulted in a significant enhancement of NK cytotoxicity against various cancer cell lines. Most importantly, administration of G{\"o}6983 effectively inhibited pulmonary tumor metastasis in mice in a dose-dependent manner. These results suggest that G{\"o}6983 functions as an NK cell activating molecule (NKAM); this NKAM is a novel anti-cancer and anti-metastasis drug candidate because it enhances NK cytotoxicity against cancer cells in vivo as well as in vitro.",
author = "Kim, {Hyung Ran} and Lee, {Kyoung Ho} and Park, {Su Jung} and Kim, {So Young} and Yang, {Young Keun} and Jinsung Tae and Jongsun Kim",
year = "2009",
month = "10",
day = "1",
doi = "10.1007/s00262-009-0680-0",
language = "English",
volume = "58",
pages = "1691--1700",
journal = "Cancer Immunology and Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "10",

}

Anti-cancer activity and mechanistic features of a NK cell activating molecule. / Kim, Hyung Ran; Lee, Kyoung Ho; Park, Su Jung; Kim, So Young; Yang, Young Keun; Tae, Jinsung; Kim, Jongsun.

In: Cancer Immunology, Immunotherapy, Vol. 58, No. 10, 01.10.2009, p. 1691-1700.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Anti-cancer activity and mechanistic features of a NK cell activating molecule

AU - Kim, Hyung Ran

AU - Lee, Kyoung Ho

AU - Park, Su Jung

AU - Kim, So Young

AU - Yang, Young Keun

AU - Tae, Jinsung

AU - Kim, Jongsun

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Natural cytotoxicity receptors (NCRs) are major activating receptors involved in NK cytotoxicity. NCR expression varies with the activation state of NK cells, and the expression level correlates with NK cells' natural cytotoxicity. In this study, we found that Gö6983, a PKC inhibitor, induced a remarkable increase of NCR expression on primary NK cells, but other PKC inhibitors and NK cell stimulators such as IL-2 and PMA, did not. Gö6983 increased the expression of NCR in a time- and concentration-dependent manner. Furthermore, Gö6983 strongly upregulated the surface expression of death ligands FasL and TRAIL, but not cytotoxic molecules perforin and granzyme B. Unlike two other NK stimulating molecules, IL-2, and PMA, Gö6983 did not induce NK cell proliferation. Up-regulation of NCRs and death ligands on NK cells by Gö6983 resulted in a significant enhancement of NK cytotoxicity against various cancer cell lines. Most importantly, administration of Gö6983 effectively inhibited pulmonary tumor metastasis in mice in a dose-dependent manner. These results suggest that Gö6983 functions as an NK cell activating molecule (NKAM); this NKAM is a novel anti-cancer and anti-metastasis drug candidate because it enhances NK cytotoxicity against cancer cells in vivo as well as in vitro.

AB - Natural cytotoxicity receptors (NCRs) are major activating receptors involved in NK cytotoxicity. NCR expression varies with the activation state of NK cells, and the expression level correlates with NK cells' natural cytotoxicity. In this study, we found that Gö6983, a PKC inhibitor, induced a remarkable increase of NCR expression on primary NK cells, but other PKC inhibitors and NK cell stimulators such as IL-2 and PMA, did not. Gö6983 increased the expression of NCR in a time- and concentration-dependent manner. Furthermore, Gö6983 strongly upregulated the surface expression of death ligands FasL and TRAIL, but not cytotoxic molecules perforin and granzyme B. Unlike two other NK stimulating molecules, IL-2, and PMA, Gö6983 did not induce NK cell proliferation. Up-regulation of NCRs and death ligands on NK cells by Gö6983 resulted in a significant enhancement of NK cytotoxicity against various cancer cell lines. Most importantly, administration of Gö6983 effectively inhibited pulmonary tumor metastasis in mice in a dose-dependent manner. These results suggest that Gö6983 functions as an NK cell activating molecule (NKAM); this NKAM is a novel anti-cancer and anti-metastasis drug candidate because it enhances NK cytotoxicity against cancer cells in vivo as well as in vitro.

UR - http://www.scopus.com/inward/record.url?scp=68549109648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68549109648&partnerID=8YFLogxK

U2 - 10.1007/s00262-009-0680-0

DO - 10.1007/s00262-009-0680-0

M3 - Article

VL - 58

SP - 1691

EP - 1700

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 10

ER -